Bayer sees improvement in 2026 after profit decline this year

FRANKFURT (Reuters) - Bayer on Wednesday raised the prospect of a return to earnings growth next year after reiterating that a decline was expected for this year.

In a statement, the German maker of drugs and farming pesticides said 2025 would be "the most difficult in terms of financial performance, with net sales roughly in line with and earnings and free cash flow behind the prior year".

"The company expects improved performance from 2026 onwards," it added.

(Reporting by Ludwig Burger, Editing by Miranda Murray)